Century Therapeutics, Inc.
IPSC
$2.45
$0.156.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.85% | -10.26% | -4.27% | 372.82% | 8.44% |
| Total Depreciation and Amortization | 6.99% | -5.12% | -7.54% | -0.15% | -6.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -153.92% | 174.80% | 917.33% | -50.25% | -46.50% |
| Change in Net Operating Assets | 72.57% | 71.35% | -198.74% | -1,184.68% | 162.86% |
| Cash from Operations | 33.63% | 9.70% | -0.95% | -14.46% | 7.65% |
| Capital Expenditure | 190.26% | -124.25% | -19.62% | 11.87% | 84.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.81% | -35.20% | 236.95% | 135.14% | 57.18% |
| Cash from Investing | -26.94% | -37.06% | 196.09% | 142.01% | 64.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -100.00% | -99.34% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -69.10% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 108.80% | -100.00% | -100.00% | -99.34% | -69.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.62% | -108.20% | 209.96% | -1,183.79% | 172.42% |